1887

Abstract

Antibodies play a pivotal role against viral infection, and maintenance of protection is dependent on plasma and memory B-cells. Understanding antigen-specific B-cell responses in cattle is essential to inform future vaccine design. We have previously defined T-cell-dependent and -independent B-cell responses in cattle, as a prelude to investigating foot-and-mouth-disease-virus (FMDV)-specific B-cell responses. In this study, we have used an FMDV O-serotype vaccination (O-Manisa or O SKR) and live-virus challenge (FMDV O SKR) to investigate the homologous and heterologous B-cell response in cattle following both vaccination and live-virus challenge. The FMDV O-serotype vaccines were able to induce a cross-reactive plasma-cell response, specific for both O-Manisa and O SKR, post-vaccination. Post-FMDV O SKR live-virus challenge, the heterologous O-Manisa vaccination provided cross-protection against O SKR challenge and cross-reactive O SKR-specific plasma cells were induced. However, vaccination and live-virus challenge were not able to induce a detectable FMDV O-serotype-specific memory B-cell response in any of the cattle. The aim of new FMDV vaccines should be to induce memory responses and increased duration of immunity in cattle.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.000517
2016-09-01
2020-04-04
Loading full text...

Full text loading...

/deliver/fulltext/jgv/97/9/2201.html?itemId=/content/journal/jgv/10.1099/jgv.0.000517&mimeType=html&fmt=ahah

References

  1. Aiba Y., Kometani K., Hamadate M., Moriyama S., Sakaue-Sawano A., Tomura M., Luche H., Fehling H. J., Casellas R. et al. 2010; Preferential localization of IgG memory B cells adjacent to contracted germinal centers. Proc Natl Acad Sci U S A107:12192–12197 [CrossRef][PubMed]
    [Google Scholar]
  2. Bachmann M. F., Zinkernagel R. M.. 1997; Neutralizing antiviral B cell responses. Annu Rev Immunol15:235–270 [CrossRef][PubMed]
    [Google Scholar]
  3. Baumgarth N.. 2013; How specific is too specific? B-cell responses to viral infections reveal the importance of breadth over depth. Immunol Rev255:82–94 [CrossRef][PubMed]
    [Google Scholar]
  4. Bernasconi N. L., Traggiai E., Lanzavecchia A.. 2002; Maintenance of serological memory by polyclonal activation of human memory B cells. Science298:2199–2202 [CrossRef][PubMed]
    [Google Scholar]
  5. Brehm K. E., Kumar N., Thulke H. H., Haas B.. 2008; High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus. Vaccine26:1681–1687 [CrossRef][PubMed]
    [Google Scholar]
  6. Carr B. V., Lefevre E. A., Windsor M. A., Inghese C., Gubbins S., Prentice H., Juleff N. D., Charleston B.. 2013; CD4+ T-cell responses to foot-and-mouth disease virus in vaccinated cattle. J Gen Virol94:97–107 [CrossRef][PubMed]
    [Google Scholar]
  7. Cunliffe H. R.. 1964; Observations on the duration of immunity in cattle after experimental infection with foot-and-mouth disease virus. Cornell Vet54:501–510
    [Google Scholar]
  8. Doel T. R.. 1996; Natural and vaccine-induced immunity to foot and mouth disease: the prospects for improved vaccines. Rev Sci Tech15:883–911[PubMed]
    [Google Scholar]
  9. Fehr T., Bachmann M. F., Bluethmann H., Kikutani H., Hengartner H., Zinkernagel R. M.. 1996; T-independent activation of B cells by vesicular stomatitis virus: no evidence for the need of a second signal. Cell Immunol168:184–192 [CrossRef][PubMed]
    [Google Scholar]
  10. Feldmann M., Easten A.. 1971; The relationship between antigenic structure and the requirement for thymus-derived cells in the immune response. J Exp Med134:103–119[PubMed][CrossRef]
    [Google Scholar]
  11. Grant C. F., Lefevre E. A., Carr B. V., Prentice H., Gubbins S., Pollard A. J., Charreyre C., Charleston B.. 2012; Assessment of T-dependent and T-independent immune responses in cattle using a B cell ELISPOT assay. Vet Res43:68 [CrossRef][PubMed]
    [Google Scholar]
  12. Halliley J. L., Kyu S., Kobie J. J., Walsh E. E., Falsey A. R., Randall T. D., Treanor J., Feng C., Sanz I., Lee F. E.. 2010; Peak frequencies of circulating human influenza-specific antibody secreting cells correlate with serum antibody response after immunization. Vaccine28:3582–3587 [CrossRef][PubMed]
    [Google Scholar]
  13. Hamblin C., Barnett I. T., Hedger R. S.. 1986; A new enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus. I. Development and method of ELISA. J Immunol Methods93:115–121[PubMed][CrossRef]
    [Google Scholar]
  14. Juleff N., Windsor M., Reid E., Seago J., Zhang Z., Monaghan P., Morrison I. W., Charleston B.. 2008; Foot-and-mouth disease virus persists in the light zone of germinal centres. PLoS One3:e3434 [CrossRef][PubMed]
    [Google Scholar]
  15. Juleff N., Windsor M., Lefevre E. A., Gubbins S., Hamblin P., Reid E., McLaughlin K., Beverley P. C., Morrison I. W., Charleston B.. 2009; Foot-and-mouth disease virus can induce a specific and rapid CD4+ T-cell-independent neutralizing and isotype class-switched antibody response in naïve cattle. J Virol83:3626–3636 [CrossRef][PubMed]
    [Google Scholar]
  16. Kelly D. F., Snape M. D., Cutterbuck E. A., Green S., Snowden C., Diggle L., Yu L. M., Borkowski A., Moxon E. R. et al. 2006; CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen-specific memory B cells. Blood108:2642–2647 [CrossRef][PubMed]
    [Google Scholar]
  17. Kitching R. P., Barnett P., Paton D. J., MacKay D.. 2008; Foot and mouth disease. In Manual of Diagnostic Tests and Vaccines for Terrestrial Animals (Mammals, Birds and Bees), 6th edn. pp.145–173 Paris: Office international des epizooties (OIE);
    [Google Scholar]
  18. Lee B. O., Rangel-Moreno J., Moyron-Quiroz J. E., Hartson L., Makris M., Sprague F., Lund F. E., Randall T. D.. 2005; CD4 T cell-independent antibody response promotes resolution of primary influenza infection and helps to prevent reinfection. J Immunol175:5827–5838[PubMed][CrossRef]
    [Google Scholar]
  19. Lee F. E., Falsey A. R., Halliley J. L., Sanz I., Walsh E. E.. 2010; Circulating antibody-secreting cells during acute respiratory syncytial virus infection in adults. J Infect Dis202:1659–1666 [CrossRef][PubMed]
    [Google Scholar]
  20. Lefevre E. A., Carr B. V., Prentice H., Charleston B.. 2009; A quantitative assessment of primary and secondary immune responses in cattle using a B cell ELISPOT assay. Vet Res40:3 [CrossRef][PubMed]
    [Google Scholar]
  21. Martin W. B., Chapman W. G.. 1961; The tissue culture colour test for assaying the virus and neutralizing antibody of foot and mouth disease and its application to the measurement of immunity in cattle. Research in Veterinary Science2:53–61
    [Google Scholar]
  22. McHeyzer-Williams M. G.. 2003; B cells as effectors. Curr Opin Immunol15:354–361[PubMed][CrossRef]
    [Google Scholar]
  23. Ndungu F. M., Cadman E. T., Coulcher J., Nduati E., Couper E., Macdonald D. W., Ng D., Langhorne J.. 2009; Functional memory B cells and long-lived plasma cells are generated after a single Plasmodium chabaudi infection in mice. PLoS Pathog5:e1000690 [CrossRef][PubMed]
    [Google Scholar]
  24. Nieminen T., Eskola J., Käyhty H.. 1998; Pneumococcal conjugate vaccination in adults: circulating antibody secreting cell response and humoral antibody responses in saliva and in serum. Vaccine16:630–636 [CrossRef][PubMed]
    [Google Scholar]
  25. Pega J., Bucafusco D., Di Giacomo S., Schammas J. M., Malacari D., Capozzo A. V., Arzt J., Pérez-Beascoechea C., Maradei E. et al. 2013; Early adaptive immune responses in the respiratory tract of foot-and-mouth disease virus-infected cattle. J Virol87:2489–2495 [CrossRef][PubMed]
    [Google Scholar]
  26. Pega J., Di Giacomo S., Bucafusco D., Schammas J. M., Malacari D., Barrionuevo F., Capozzo A. V., Rodríguez L. L., Borca M. V., Pérez-Filgueira M.. 2015; Systemic foot-and-mouth disease vaccination in cattle promotes specific antibody-secreting cells at the respiratory tract and triggers local anamnestic responses upon aerosol infection. J Virol89:9581–9590 [CrossRef][PubMed]
    [Google Scholar]
  27. Porta C., Kotecha A., Burman A., Jackson T., Ren J., Loureiro S., Jones I. M., Fry E. E., Stuart D. I., Charleston B.. 2013; Rational engineering of recombinant picornavirus capsids to produce safe, protective vaccine antigen. PLoS Pathog9:e1003255 [CrossRef][PubMed]
    [Google Scholar]
  28. Reed L. J., Muench H.. 1938; A simple method of estimating fifty per cent endpoints. Am J Epidemiol27:493–497
    [Google Scholar]
  29. Wrammert J., Smith K., Miller J., Langley W. A., Kokko K., Larsen C., Zheng N. Y., Mays I., Garman L. et al. 2008; Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature453:667–671 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.000517
Loading
/content/journal/jgv/10.1099/jgv.0.000517
Loading

Data & Media loading...

Most cited this month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error